» Human kallikrein

RESEARCH ENZYMES KALLIKREIN

Human kallikrein

Formulation : 1mg in a buffer composed of 4mM sodium acetate / hydrochloride, 150mM NaCl, pH 5.3

MW(Da) : 85 000
Structure : 52 kDa heavy chain and a 33 kDa light chain linked by disulfide bridges.
Coef. Extinction : 1.17

Reference	Presentation	Packaging
11-473	Vial	1 mg

The Safety Data Sheets and Notices are accessible to our registered customers.

Kallikrein is a glycoprotein derived from prekallikrein. It is non-covalently complexed to the high molecular weight kininogen. FXIIa activates the transformation of prekallikrein into kallikrein which will activate FXII and hydrolyze KHPM into several fragments. In fibrinolysis, kallikrein is also able to activate pro-urokinase to urokinase.

All proteins are accompanied by certificates of analysis which describe the appropriate storage conditions. In order for us to guarantee the stability of the product, it is imperative that the storage conditions are observed. Avoid freezing and thawing cycles.

The lyophilized presentation allows greater stability until the expiration date.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.

You must identify yourself to search for a certificate of analysis

RESEARCH ENZYMES KALLIKREIN

Human kallikrein

Download the catalog brochure

The Safety Data Sheets and Notices are accessible to our registered customers.